Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer therapy. Its structure enables selective binding to protein targets involved in cell signaling pathways, making it valuable in the design of targeted treatments for oncology. Commonly employed in research settings to optimize drug candidates with improved potency and metabolic stability. Also utilized in medicinal chemistry for structure-activity relationship (SAR) studies due to its ability to enhance bioavailability and receptor affinity.